What is Capricor Therapeutics's deferred revenue?

Capricor Therapeutics (CAPR) reported deferred revenue of $12M in Q1 2026.

How has Capricor Therapeutics's deferred revenue changed year-over-year?

Capricor Therapeutics's deferred revenue decreased by 0.0% year-over-year, from $12M to $12M.

What does deferred revenue mean?

Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Capricor Therapeutics CAPR Deferred Revenue

Deferred Revenue at other companies

Sarepta Therapeutics, Inc.SRPT

$116.04M+159%

PTC TherapeuticsPTCT

$498K-96.1%

Viridian Therapeutics, Inc.VRDN

$274K-4.9%

CytokineticsCYTK

$1.65M-96.8%

CRISPR TherapeuticsCRSP

$15.34M+408%

MedtronicMDT

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Enterprise value$1.62B+308%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's deferred revenue?: Capricor Therapeutics (CAPR) reported deferred revenue of $12M in Q1 2026.
How has Capricor Therapeutics's deferred revenue changed year-over-year?: Capricor Therapeutics's deferred revenue decreased by 0.0% year-over-year, from $12M to $12M.
What does deferred revenue mean?: Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.